Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study
- 22 June 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 359 (9324) , 2145-2152
- https://doi.org/10.1016/s0140-6736(02)09090-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Prevention and Management of Platelet Transfusion RefractorinessVox Sanguinis, 1999
- Autologous Platelet Collection and Storage to Support Thrombocytopenia in Patients Undergoing High‐Dose Chemotherapy and Circulating Progenitor Cell Transplantation for High‐Risk Breast CancerVox Sanguinis, 1998
- Cryopreservation of single‐donor platelets with a reduced dimethyl sulfoxide concentration by the addition of second‐messenger effectors: enhanced retention of in vitro functional activityTransfusion, 1998
- Recovery of in vitro functional activity of platelet concentrates stored at 4 ° C and treated with second‐messenger effectorsTransfusion, 1996
- Cryopreservation of human platelets with dimethyl sulfoxide: changes in biochemistry and cell functionTransfusion, 1995
- Collection and transfusion of blood and blood components in the United States, 1992Transfusion, 1995
- Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patientsTransfusion, 1995
- Morphological and functional disturbances of platelets induced by cryopreservation.Journal of Clinical Pathology, 1982
- Transfusion experience with platelet concentrates stored for 24 to 72 hours at 22° CTransfusion, 1982
- Frozen Autologous Platelet Transfusion for Patients with LeukemiaNew England Journal of Medicine, 1978